July, 2022

Pharmac issue RFP for immunotherapy

We are pleased to finally see a RFP for lung cancer immunotherapy issued. When immunotherapy treatment is funded for stage four lung cancer (NSCLC), it will be life changing for approximately 26 patients every week.. The combined voice of; patients, carers, patients family’s, health care professionals, specialists, researchers, advocates and community has made this possible. […]

Lung Foundation at the NZ Lung Cancer Conference

Lung Foundation New Zealand representatives; Chief Executive, Philip Hope and Assoc Prof of Oncology, Chris Atkinson attended and presented at the NZ Lung Cancer Conference. 2022 July – NZ Lung Cancer Conference Click to view the conference programme. https://az659834.vo.msecnd.net/eventsairseasiaprod/production-outshine-public/0fa313da4ba547a5a8d74d4cdb36241e